1-12 of 12
heparin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2

Clinical Trials & Observations
Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann, Zitta Barrella Harboe, Casper Roed, Tomas Ø. Jensen, Lilian Kolte, Daniel El Fassi, Jens Hillingsø, Aneta Radziwon-Balicka, Robert Sebastian Soyka, Klaus Hansen, Nikolai Kirkby, Jens P. Goetze, Mikkel Gybel-Brask, Eva Birgitte Leinøe, Anne-Mette Hvas, Peter Kampmann, Jakob Stensballe
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2569–2574.
https://doi.org/10.1182/bloodadvances.2021004904
Published: 2021
Journal Articles

The management of venous thromboembolism in hospitalized patients with COVID-19

Clinical Trials & Observations
Alex C. Spyropoulos
Journal: Blood Advances
Blood Adv (2020) 4 (16): 4028.
https://doi.org/10.1182/bloodadvances.2020002496
Published: 2020
Includes: Supplemental data
Journal Articles

Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies

Ray Zhang, Brian F. Duffy, Vinzenz Lange, Charles S. Eby, Chang Liu
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3136–3142.
https://doi.org/10.1182/bloodadvances.2019000311
Published: 2019
Journal Articles

Heterogeneity in neutrophil responses to immune complexes

Madelaine Duarte, Maragatha Kuchibhatla, Sanjay Khandelwal, Gowthami M. Arepally, Grace M. Lee
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2778–2789.
https://doi.org/10.1182/bloodadvances.2019000235
Published: 2019
Includes: Supplemental data
Journal Articles

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors

Manu T. Kalathottukaren, A. Louise Creagh, Srinivas Abbina, Genmin Lu, Mark J. Karbarz, Anjali Pandey, Pamela B. Conley, Jayachandran N. Kizhakkedathu, Charles Haynes
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2104–2114.
https://doi.org/10.1182/bloodadvances.2016003616
Published: 2018
Includes: Supplemental data
Journal Articles

Tkaczynski E, Arulselvan A, Tkaczynski J, et al. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia. Blood Adv . 2018;2(7):754-761.

Journal: Blood Advances
Blood Adv (2018) 2 (10): 1129.
https://doi.org/10.1182/bloodadvances.2018020461
Published: 2018
Journal Articles

2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia

Elizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski, Stephen Avery, Liqing Xiao, Beverly Torok-Storb, Kraig Abrams, Narayanam V. Rao, Gregory Johnson, Thomas P. Kennedy, Mortimer Poncz, Michele P. Lambert
Journal: Blood Advances
Blood Adv (2018) 2 (7): 754–761.
https://doi.org/10.1182/bloodadvances.2017013672
Published: 2018
Includes: Supplemental data
Journal Articles

Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia

Clinical Trials & Observations
Tibor J. Kovacsovics, Alice Mims, Mohamed E. Salama, Jeremy Pantin, Narayanam Rao, Ken M. Kosak, Peter Ahorukomeye, Martha J. Glenn, Michael W. N. Deininger, Kenneth M. Boucher, Linda M. Bavisotto, Gerardo Gutierrez-Sanchez, Thomas P. Kennedy, Stephen G. Marcus, Paul J. Shami
Journal: Blood Advances
Blood Adv (2018) 2 (4): 381–389.
https://doi.org/10.1182/bloodadvances.2017013391
Published: 2018
Journal Articles

Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins

Amy K. L. Chui, Tilini N. Gunatillake, Vera Ignjatovic, Paul T. Monagle, Padma Murthi, Shaun P. Brennecke, John M. Whitelock, Joanne M. Said
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1243–1253.
https://doi.org/10.1182/bloodadvances.2017004333
Published: 2017
Journal Articles

Serologic characterization of anti-protamine/heparin and anti-PF4/heparin antibodies

Grace M. Lee, Manali Joglekar, Maragatha Kuchibhatla, Sanjay Khandelwal, Rui Qi, Lubica Rauova, Gowthami M. Arepally
Journal: Blood Advances
Blood Adv (2017) 1 (11): 644–651.
https://doi.org/10.1182/bloodadvances.2017004408
Published: 2017
Includes: Supplemental data
Journal Articles

Should we avoid heparin to eliminate HIT?

Gowthami Morey Arepally
Journal: Blood Advances
Blood Adv (2016) 1 (1): 4.
https://doi.org/10.1182/bloodadvances.2016000083
Published: 2016
Includes: Supplemental data
Journal Articles

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia

Douglas B. Cines, Serge V. Yarovoi, Sergei V. Zaitsev, Tatiana Lebedeva, Lubica Rauova, Mortimer Poncz, Gowthami M. Arepally, Sanjay Khandelwal, Victoria Stepanova, Ann H. Rux, Adam Cuker, Cecilia Guo, Linnette Mae Ocariza, Richard J. Travers, Stephanie A. Smith, Hugh Kim, James H. Morrissey, Edward M. Conway
Journal: Blood Advances
Blood Adv (2016) 1 (1): 62–74.
https://doi.org/10.1182/bloodadvances.2016000877
Published: 2016
Includes: Supplemental data